Selecta Biosciences Inc., of Watertown Mass., said it entered definitive agreements to sell securities in a private placement that is expected to result in gross proceeds of $50 million. Certain new and existing institutional investors agreed to purchase an aggregate of 2.75 million shares of common stock at $16 each.